Biogen Inc. has begun eliminating positions as part of a long-promised cost-saving measure in the wake of the fallout from its Alzheimer's drug.
The Cambridge company confirmed the layoffs in an email to the Business Journal on Thursday. A spokesperson declined to offer many details, including exactly how many people are losing their jobs, but she said that "some of our colleagues in the U.S. were recently informed that their roles are being eliminated."
The company will also hold off on filling many open positions.
More on this story from Boston Business Journal
Get Boston local news, weather forecasts, lifestyle and entertainment stories to your inbox. Sign up for NBC Boston’s newsletters.
Copyright Boston Business Journal
